Carmichael Hill & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.34M Buy
6,760
+71
+1% +$14K 0.47% 48
2024
Q2
$1.15M Buy
6,689
+13
+0.2% +$2.23K 0.45% 50
2024
Q1
$1.22M Buy
6,676
+12
+0.2% +$2.19K 0.48% 50
2023
Q4
$1.03M Buy
6,664
+14
+0.2% +$2.17K 0.43% 54
2023
Q3
$991K Buy
6,650
+13
+0.2% +$1.94K 0.46% 52
2023
Q2
$894K Buy
6,637
+1,213
+22% +$163K 0.4% 56
2023
Q1
$864K Buy
5,424
+134
+3% +$21.4K 0.42% 54
2022
Q4
$855K Sell
5,290
-3
-0.1% -$485 0.44% 50
2022
Q3
$710K Buy
5,293
+11
+0.2% +$1.48K 0.38% 58
2022
Q2
$809K Sell
5,282
-991
-16% -$152K 0.42% 52
2022
Q1
$1.02M Buy
6,273
+1,094
+21% +$177K 0.47% 44
2021
Q4
$701K Buy
5,179
+36
+0.7% +$4.87K 0.31% 61
2021
Q3
$555K Buy
5,143
+12
+0.2% +$1.3K 0.28% 70
2021
Q2
$578K Buy
5,131
+21
+0.4% +$2.37K 0.29% 67
2021
Q1
$553K Buy
5,110
+34
+0.7% +$3.68K 0.3% 67
2020
Q4
$544K Buy
5,076
+694
+16% +$74.4K 0.32% 63
2020
Q3
$384K Buy
4,382
+267
+6% +$23.4K 0.26% 77
2020
Q2
$404K Buy
4,115
+580
+16% +$56.9K 0.3% 69
2020
Q1
$269K Buy
3,535
+126
+4% +$9.59K 0.24% 83
2019
Q4
$302K Sell
3,409
-73
-2% -$6.47K 0.21% 88
2019
Q3
$264K Sell
3,482
-319
-8% -$24.2K 0.26% 88
2019
Q2
$276K Sell
3,801
-62
-2% -$4.5K 0.27% 90
2019
Q1
$311K Sell
3,863
-97
-2% -$7.81K 0.32% 81
2018
Q4
$365K Sell
3,960
-113
-3% -$10.4K 0.42% 69
2018
Q3
$385K Buy
4,073
+2
+0% +$189 0.37% 73
2018
Q2
$377K Buy
4,071
+2
+0% +$185 0.41% 69
2018
Q1
$385K Buy
4,069
+2
+0% +$189 0.42% 69
2017
Q4
$393K Buy
+4,067
New +$393K 0.43% 71